Ask AI

Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment

Improve your knowledge of new and emerging therapies and updated guidelines for multiple myeloma for optimal integration into practice and personalized treatment strategies through a certified on-demand webcast with accompanying downloadable slides and an expert-written ClinicalThought commentary.

Share

Program Content

Activities

New Data and Updated Guidelines in MM
Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2025

Newly Diagnosed MM
MM Confirmed: What Are Next Steps for Optimal Treatment of Newly Diagnosed MM?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2025

New Treatment Options in RR MM
Updates on New Treatment Options in Relapsed/Refractory Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2025

Activities

New Data and Updated Guidelines in MM
Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2025

Expires: June 18, 2026

Activities

Real World FAQs in Multiple Myeloma
Expert Perspectives on Real-world Decision-making in Multiple Myeloma: Answers to Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2025

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC.

Supporters

Supported by independent medical education grants from AbbVie and GSK.
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Supported by a medical education grant from Karyopharm Therapeutics.

AbbVie

GSK

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner